Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

Also called NCT06271577

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
  • AliveCor Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06271577
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06271577. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-12 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
Acronym
STLEUISII
Condition
Ischemia
Condition
Myocardial Ischemia
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Condition
Vascular Diseases
Condition
Heart Attack
Condition
Heart Failure
Intervention (Device)
AliveCor 12-lead ECG (electrocardiogram)
Lead sponsor
AliveCor (class: industry)

Record details

Record id
cardio:ct-nct06271577
Content hash
b1d21393aa7de6116372d9bc3d18e039dc03411928f5a6ead0ddd38faeca1fc8